论文部分内容阅读
Cefpirome(CPR)是一种广谱头孢菌素,对绿脓杆菌的抗菌活力介于Ceftazidime和头孢哌酮之间,对葡萄球菌属具有良好的抗菌活力。本药对成人的Ⅱ期临床试验已经结束,并报告了其安全性和有效性。本文介绍CPR用于小儿科的临床试验的
Cefpirome (CPR) is a broad-spectrum cephalosporin. Its antibacterial activity against Pseudomonas aeruginosa is between Ceftazidime and cefoperazone, and has good antibacterial activity against Staphylococcus. Phase II clinical trial of the drug in adults has ended, and reported its safety and effectiveness. This article describes the use of CPR in pediatric clinical trials